News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,495 Results
Type
Article (39474)
Company Profile (249)
Press Release (653772)
Section
Business (204056)
Career Advice (2006)
Deals (35412)
Drug Delivery (93)
Drug Development (80980)
Employer Resources (169)
FDA (16139)
Job Trends (14831)
News (344947)
Policy (32480)
Tag
Academia (2537)
Alliances (49331)
Alzheimer's disease (1317)
Approvals (16125)
Artificial intelligence (211)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (177)
Breast cancer (230)
Cancer (1770)
Cardiovascular disease (132)
Career advice (1670)
CAR-T (128)
Cell therapy (368)
Clinical research (65364)
Collaboration (688)
Compensation (379)
COVID-19 (2569)
C-suite (171)
Data (1687)
Diabetes (221)
Diagnostics (6298)
Earnings (85654)
Employer resources (145)
Events (111102)
Executive appointments (583)
FDA (17079)
Funding (619)
Gene therapy (252)
GLP-1 (657)
Government (4363)
Healthcare (18784)
Infectious disease (2686)
Interviews (311)
IPO (16467)
Job creations (3627)
Job search strategy (1421)
Layoffs (440)
Legal (7890)
Lung cancer (259)
Manufacturing (241)
Medical device (13275)
Medtech (13280)
Mergers & acquisitions (19337)
Metabolic disorders (572)
Neuroscience (1734)
NextGen: Class of 2025 (6509)
Non-profit (4476)
Northern California (2177)
Obesity (314)
Opinion (198)
Patents (174)
People (56895)
Phase I (20352)
Phase II (28790)
Phase III (21444)
Pipeline (780)
Postmarket research (2563)
Preclinical (8587)
Radiopharmaceuticals (242)
Rare diseases (331)
Real estate (5897)
Regulatory (21973)
Research institute (2314)
Resumes & cover letters (349)
Southern California (1867)
Startups (3569)
United States (19133)
Vaccines (620)
Weight loss (214)
Date
Today (111)
Last 7 days (778)
Last 30 days (2687)
Last 365 days (34341)
2025 (5335)
2024 (35223)
2023 (40083)
2022 (51175)
2021 (55711)
2020 (54085)
2019 (46541)
2018 (35018)
2017 (32126)
2016 (31488)
2015 (37555)
2014 (31318)
2013 (26345)
2012 (28571)
2011 (29263)
2010 (27329)
Location
Africa (717)
Arizona (211)
Asia (37549)
Australia (6138)
California (4962)
Canada (1748)
China (410)
Colorado (226)
Connecticut (234)
Europe (80496)
Florida (730)
Georgia (171)
Illinois (463)
Indiana (271)
Japan (126)
Maryland (757)
Massachusetts (3768)
Michigan (200)
Minnesota (344)
New Jersey (1404)
New York (1420)
North Carolina (855)
Northern California (2177)
Ohio (174)
Pennsylvania (1128)
South America (1093)
Southern California (1867)
Texas (725)
Utah (153)
Washington State (475)
693,495 Results for "exelixis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pipeline
Exelixis Looks to Next-Gen Cancer Drug as Cabometyx Underwhelms Again
Exelixis’ next-generation tyrosine kinase inhibitor zanzalintinib is being tested for colorectal cancer, renal cell carcinoma and head-and-neck cancer, with several readouts slated for the second half of 2025.
February 19, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Exelixis to Participate in the Citi 2025 Virtual Oncology Leadership Summit
February 14, 2025
·
1 min read
Press Releases
Exelixis Announces a Newly Authorized $500 Million Stock Repurchase Program
February 21, 2025
·
3 min read
Press Releases
Exelixis Announces Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Corporate Update
February 12, 2025
·
20 min read
Press Releases
Exelixis to Release Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025
January 28, 2025
·
1 min read
Biotech Bay
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May 2024
Exelixis, Inc. announced that members of the company’s management team will participate in fireside chats at the following investor conferences in May.
May 7, 2024
·
2 min read
Policy
Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
Exelixis, Inc. (Nasdaq: EXEL) today announced that it has entered into a Settlement and License Agreement (Agreement) with Cipla Ltd. and Cipla USA, Inc. (collectively Cipla).
May 20, 2024
·
3 min read
Press Releases
Exelixis to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025
January 7, 2025
·
1 min read
Biotech Bay
Exelixis to Present at the William Blair 44th Annual Growth Stock Conference
Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in a fireside chat at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4 at 4:20 p.m. ET / 3:20 p.m. CT / 1:20 p.m. PT in Chicago.
May 28, 2024
·
1 min read
Press Releases
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in December 2024
November 27, 2024
·
1 min read
1 of 69,350
Next
